Arryn T. Blaine
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
16
Citations
129
Est. group size
~1
Recurring co-author estimate
Active years
7
Publishing since 2018
Arryn T. Blaine's research focuses on opioid receptors, particularly the delta and mu subtypes, examining how different drug-like molecules bind to and activate these receptors in the brain. A recurring theme is understanding how certain opioid drugs can cause seizures, and how signaling proteins called beta-arrestins contribute to both therapeutic effects and side effects. This work combines chemistry (designing new receptor-targeting molecules) with pharmacology (testing how they affect brain signaling and behavior in animal models).
Publication output rose to a peak around 2019-2021 but has slowed in recent years, averaging fewer than one publication per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype
Journal of Pharmacology and Experimental Therapeutics · 2024
- Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures
Neuropharmacology · 2023
- Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
Frontiers in Pharmacology · 2022
- Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands
RSC Medicinal Chemistry · 2021
- Role of β‐arrestin Isoforms in Delta Opioid Receptor Agonist‐Induced Seizures
The FASEB Journal · 2021
- Modulating β Arrestin-2 Recruitment at the δ- and μ-Opioid Receptors
ChemRxiv · 2020
- Modulating β Arrestin-2 Recruitment at the δ- and μ-Opioid Receptors
ChemRxiv · 2020
- Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice
Frontiers in Neuroscience · 2019
- The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
Molecules · 2019
- The Meta-Position of Phe <sup>4</sup> in Leu-enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
bioRxiv (Cold Spring Harbor Laboratory) · 2019
- The FASEB Journal×4
- Frontiers in Pharmacology×2
- ChemRxiv×2
- Journal of Biological Chemistry×1
- Neuropharmacology×1
- Val J. Watts
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Richard M. van Rijn
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Wolfgang Sadée
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Berkay Selçuk
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Val J. Watts
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile